COMPANY
Company
OCELLBIO is MediShift's dedicated medical R&D subsidiary, focused on cell anti-aging technology research and medical infrastructure supply.
OCELLBIO is a core subsidiary established in July 2026 by MediShift Inc., a specialized medical service organization (MSO) and medical business platform brand.
It is dedicated to the core research and development (R&D) and customized medical solution supply of MediShift's medical wellness business, and forms strong synergy with Ocell Clinic, a premium medical brand that recently opened.
OCELLBIO leads the advancement and standardization of sophisticated anti-aging technologies, including the PRP/PRF autologous activated cell therapy program and stem cell injections (blood, bone marrow, adipose, cultured) and NK cell injection therapy, and is expanding its business beyond Ocell Clinic supply into the B2B market for hospitals and clinics nationwide.
- Company Name
- OCELLBIO Inc.
- English Name
- OCELLBIO Inc.
- CEO
- Jason Kim
- Address
- 4F, 23 Hakdong-ro 46-gil, Gangnam-gu, Seoul, Republic of Korea
Partnership Inquiry
If you are interested in collaborating on cultured cell supply, clean room/clean booth construction, or technology partnerships, please contact us using the form below.